Bolt Biotherapeutics, Inc. (BOLT)
3.86
-0.04
(-1.03%)
USD |
NASDAQ |
Sep 08, 16:00
3.87
+0.01
(+0.26%)
Pre-Market: 20:00
Bolt Biotherapeutics Gross Profit Margin (Quarterly) : -3.32K% for June 30, 2026
Gross Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -3.32K% |
| March 31, 2026 | -680.8% |
| December 31, 2025 | 89.80% |
| September 30, 2025 | 86.63% |
| June 30, 2025 | 80.76% |
| March 31, 2025 | 67.35% |
| December 31, 2024 | |
| September 30, 2024 | 61.44% |
| June 30, 2024 | 64.16% |
| March 31, 2024 | 91.32% |
| December 31, 2023 | 76.21% |
| September 30, 2023 | 81.72% |
| June 30, 2023 | 17.03% |
| March 31, 2023 | 35.05% |
| Date | Value |
|---|---|
| December 31, 2022 | 17.29% |
| September 30, 2022 | 46.92% |
| June 30, 2022 | 0.00% |
| March 31, 2022 | -87.95% |
| December 31, 2021 | -78.15% |
| September 30, 2021 | 0.00% |
| June 30, 2021 | |
| March 31, 2021 | |
| December 31, 2020 | |
| September 30, 2020 | |
| June 30, 2020 | 0.00% |
| March 31, 2020 | 0.00% |
| December 31, 2019 | 0.00% |
| September 30, 2019 | 0.00% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit Margin (Quarterly) Benchmarks
Gross Profit Margin (Quarterly) Related Metrics
| Return on Equity | -110.6% |
| Return on Assets | -49.32% |
| Return on Invested Capital | -58.75% |
| Profit Margin (Quarterly) | -154.4K% |
| Operating Margin (Quarterly) | -151.3K% |
| Return on Net Operating Assets | -140.5% |